Parabilis Medicines, Inc. (PBLS) Insider Trading
Sector: Biotechnology · Market Cap: $4.1B · 0 insider purchases in the last 7 days
No open market insider purchases at Parabilis Medicines, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track PBLS on your watchlist.
Start for FreeAbout Parabilis Medicines, Inc. Insider Trading
2 insiders at Parabilis Medicines, Inc. (PBLS) have purchased stock in the past 90 days, totaling $16.9M across 8 transactions (744,593 shares).
The most recent purchase was by Director RA CAPITAL MANAGEMENT, L.P. on July 22, 2026 — a $1.4M buy of 47,250 shares at $29.77, bringing his total holdings to 26,529,686 shares.
Insiders who purchased: Levy Guy (10%+ Owner, 2 buys totaling $10.0M); RA CAPITAL MANAGEMENT, L.P. (Director, 6 buys totaling $6.9M).
This insider buying is notable given that PBLS had no recorded open market purchases in the nine months before that.
PBLS is in the Biotechnology sector within the Biotechnology industry with a market cap of $4.1B.
Track PBLS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.